David
Garcia Azorin
Hospital Universitario de Valladolid
Valladolid, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario de Valladolid (145)
2024
-
Acute and Preventive Treatment of COVID-19-Related Headache: A Series of 100 Patients
Life, Vol. 14, Núm. 7
-
CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine
Cephalalgia : an international journal of headache, Vol. 44, Núm. 4
-
Diagnóstico y tratamiento de los trastornos de la presión intracraneal: Documento de consenso del Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología
Neurologia
-
Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study
Pain Medicine (United States), Vol. 25, Núm. 3, pp. 194-202
-
Embolic Events in Infective Endocarditis: A Comprehensive Review
Reviews in Cardiovascular Medicine, Vol. 25, Núm. 3
-
Evaluation of the burden of migraine on the partner's lifestyle
Neurologia, Vol. 39, Núm. 9, pp. 810-819
-
Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study
European Journal of Neurology, Vol. 31, Núm. 5
-
Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010–2020 surveillance-based study
Journal of Headache and Pain, Vol. 25, Núm. 1
-
Health equity, care access and quality in headache – part 1
Journal of Headache and Pain, Vol. 25, Núm. 1
-
Improved comprehension of influenza-related headaches: Perspectives and suggestions for incidence and prevalence of headache in influenza—Response
European Journal of Neurology
-
Incidence and prevalence of headache in influenza: A 2010–2021 surveillance-based study
European Journal of Neurology, Vol. 31, Núm. 8
-
International Headache Society global practice recommendations for the acute pharmacological treatment of migraine
Cephalalgia : an international journal of headache, Vol. 44, Núm. 8
-
It is a long way to the top if you wanna citations?
Cephalalgia : an international journal of headache
-
Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
Frontiers in Neurology , Vol. 15
-
Prevalence and Trajectories of Post-COVID-19 Neurological Manifestations: A Systematic Review and Meta-Analysis
Neuroepidemiology, Vol. 58, Núm. 2, pp. 120-133
-
RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine
European Journal of Neurology, Vol. 31, Núm. 4
-
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
Journal of neurology, neurosurgery, and psychiatry, Vol. 95, Núm. 10, pp. 927-937
-
Societal and economic burden of migraine in Spain: results from the 2020 National Health and Wellness Survey
Journal of Headache and Pain, Vol. 25, Núm. 1
-
Thrombosis with thrombocytopenia syndrome following adenovirus vector-based vaccines to prevent COVID-19: Epidemiology and clinical presentation in Spain
Neurologia, Vol. 39, Núm. 9, pp. 721-732
-
Visual snow syndrome in patients with migraine: widening the clinical spectrum of the syndrome with permanent and episodic manifestations
Neurological Sciences, Vol. 45, Núm. 9, pp. 4437-4444